Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Citi
Deloitte
Teva
Chubb
Harvard Business School
QuintilesIMS
Cantor Fitzgerald

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087894

« Back to Dashboard

NDA 087894 describes SLO-BID, which is a drug marketed by Sanofi Aventis Us and is included in six NDAs. Additional details are available on the SLO-BID profile page.

The generic ingredient in SLO-BID is theophylline. There are thirty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087894
Tradename:SLO-BID
Applicant:Sanofi Aventis Us
Ingredient:theophylline
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength300MG
Approval Date:Jan 31, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
Fuji
US Army
Federal Trade Commission
Dow
Moodys
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.